Gastric Cancer Spread: New Mechanism & Potential Therapies Identified

Researchers have identified a key mechanism driving the spread of gastric cancer, offering potential novel avenues for treatment and prevention. A study from the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI) at Kanazawa University reveals that cancer cells stimulate Wnt signaling in surrounding tissue, essentially reshaping the environment to support metastasis – the process by which cancer spreads to other parts of the body.

How Cancer Cells Alter Their Surroundings

The research, published in Nature Communications, focuses on the interaction between cancer cells and stromal fibroblasts – cells that provide structural support to tissues. The team found that cancer cells activate a signaling pathway called Wnt signaling in these fibroblasts. This activation prompts the fibroblasts to produce a molecule called hyaluronan, a key component of the extracellular matrix, the network of molecules surrounding cells. Increased hyaluronan creates a microenvironment that facilitates the movement and establishment of cancer cells in distant organs.

Wnt signaling is a crucial pathway involved in many developmental processes, but it can become dysregulated in cancer. It’s known to play a role in tumor growth and progression, but this study sheds light on its specific contribution to metastasis by demonstrating how it remodels the surrounding tissue. Hyaluronan, in turn, isn’t inherently harmful. it’s a natural part of healthy tissue. Though, its overproduction, triggered by cancer cells, creates a permissive environment for spread.

Visualizing the Nano-World of Cancer

The Nano Life Science Institute (WPI-NanoLSI) at Kanazawa University plays a central role in this research, utilizing advanced microscopy techniques to observe these processes at the nanoscale. The institute, described as a “one-of-a-kind research base,” specializes in visualizing life phenomena at the atomic and molecular level. Their website highlights recent advancements, including a new method for reconstructing the dynamic movement of proteins using SimHS-AFMfit-MD, a technique that could further refine our understanding of these cellular interactions. This capability is particularly important because, as highlighted in related research from Kanazawa University, many cancer-driving proteins are highly flexible and hard to analyze with traditional methods. This research, published in January 2026, details how high-speed atomic force microscopy (HS-AFM) is being used to observe individual cancer proteins in real-time, revealing how they change shape and behavior in response to drugs.

Study Details and Limitations

While the study provides valuable insights, it’s important to consider its limitations. The research was conducted in laboratory settings, primarily using cell cultures and animal models. The extent to which these findings translate directly to human patients requires further investigation. The study doesn’t detail the specific genetic or environmental factors that might influence Wnt signaling and hyaluronan production in different individuals. The research focuses on the initial stages of metastasis; the long-term effects of this altered microenvironment on tumor growth and patient outcomes remain to be fully elucidated.

Gastric Cancer: A Global Health Challenge

Gastric cancer, also known as stomach cancer, remains a significant global health concern. According to the World Health Organization, it was estimated to be responsible for over 1.1 million new cases and over 769,000 deaths worldwide in 2020. While incidence rates have been declining in some regions due to improved prevention and treatment strategies, it remains particularly prevalent in East Asia, Eastern Europe and parts of South America. Risk factors include Helicobacter pylori infection, smoking, diet high in salted and smoked foods, and a family history of the disease.

What Does This Imply for Patients?

This research doesn’t immediately change clinical practice. However, it offers a potential new target for therapeutic intervention. Strategies aimed at blocking Wnt signaling or reducing hyaluronan production in the tumor microenvironment could potentially prevent or slow down the spread of gastric cancer. Researchers are exploring various approaches, including the development of small molecule inhibitors that specifically target Wnt signaling pathways. It’s crucial to emphasize that these are still early stages of research, and clinical trials are needed to determine the safety and efficacy of these approaches in humans.

The Path Forward: From Lab to Clinic

The next steps involve further investigation of the molecular mechanisms underlying Wnt signaling and hyaluronan production in gastric cancer. Researchers will need to identify biomarkers that can predict which patients are most likely to benefit from therapies targeting these pathways. Preclinical studies in animal models will be crucial to assess the potential toxicity and efficacy of these therapies before they can be tested in human clinical trials. Ongoing surveillance and monitoring of gastric cancer incidence and mortality rates will also be essential to track the impact of any new prevention or treatment strategies.

The work at Kanazawa University, and specifically the Nano Life Science Institute, exemplifies the growing importance of nanoscale imaging in understanding complex biological processes. By visualizing the intricate interactions between cancer cells and their environment, researchers are paving the way for more targeted and effective cancer therapies.